Nina Keldsen

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 530 citations

Medicine, Oncology, Pharmacology +16

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer

Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen et al. · The Pharmacogenomics Journal · 2010 · 96 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer

Mogens K. Boisen, Julia S. Johansen, Christian Dehlendorff et al. · Annals of Oncology · 2013 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Risk Factors for Central Nervous System Involvement in Non-Hodgkins-Lymphoma a multivariate analysis

Nina Keldsen, Wojciech Michalski, Søren M. Bentzen et al. · Acta Oncologica · 1996 · 76 citations · Full text

Medicine, Hematology, Oncology +12